See the DrugPatentWatch profile for Descovy
Descovy is a combination medication containing two active ingredients: emtricitabine and tenofovir alafenamide [1].
What is Descovy used for?
Descovy is prescribed to treat HIV-1 infection in adults and pediatric patients weighing at least 35 kg [1]. It is also used for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection in adults and adolescents weighing at least 35 kg [1].
How do emtricitabine and tenofovir alafenamide work?
Emtricitabine and tenofovir alafenamide are nucleoside reverse transcriptase inhibitors (NRTIs) [1]. They work by blocking an enzyme called reverse transcriptase, which HIV needs to make copies of itself. By inhibiting this enzyme, Descovy prevents the virus from multiplying [1].
What other components are in Descovy?
In addition to the active ingredients, Descovy contains inactive ingredients that help form the tablet. These include crospovidone, magnesium stearate, microcrystalline cellulose, and povidone [2]. The tablet is also coated with a film composed of hypromellose, lactose monohydrate, titanium dioxide, and triacetin [2].
Are there different formulations of Descovy?
Descovy is available as a single oral tablet [1].
How does Descovy compare to other HIV medications?
Descovy is one of several antiretroviral therapies used to manage HIV. It is a component of other combination HIV medications, such as Biktarvy and Genvoya, which also contain other active ingredients [3, 4]. The choice of medication depends on various factors, including individual patient characteristics and viral resistance patterns.
What are the potential side effects of Descovy?
Common side effects reported with Descovy include nausea, diarrhea, headache, dizziness, insomnia, and rash [1]. More serious side effects, although less common, can include liver problems, kidney problems, and changes in bone mineral density [1]. Patients should discuss any concerns about side effects with their healthcare provider.
When does the patent for Descovy expire?
Information regarding the specific patent expiry dates for Descovy can be found on DrugPatentWatch.com [5]. Patent protection is crucial for pharmaceutical companies to recoup research and development costs.
Can generic versions of Descovy become available?
The availability of generic versions of Descovy depends on patent expiry and any other exclusivity periods granted by regulatory agencies [5]. Once patents expire, other manufacturers may seek to produce generic alternatives, potentially increasing accessibility and reducing costs.